BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,341 | -20.5% | 186 | 0.0% | 0.00% | – |
| Q2 2023 | $11,755 | -13.2% | 186 | -38.2% | 0.00% | – |
| Q1 2023 | $13,542 | +225600.0% | 301 | +110.5% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 143 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | +12.5% | 143 | -5.3% | 0.00% | – |
| Q2 2022 | $8,000 | -20.0% | 151 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -47.4% | 151 | -15.6% | 0.00% | – |
| Q4 2021 | $19,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |